Thursday, January 22, 2015

Combining NPC1 Protein & Nanotechnology Drug Delivery System For An Ebola Antifiloviral Treatment

http://www.thecrimson.com/article/2011/9/16/ebola-cells-virus-npc1/

It's highly possible for Colorado to research, and create factories for an NPC1 Protein-based, Ebola treatment, globally. We haven't fully utilized our talented, military and veteran medical community, who have the background and biotechnology skillset to produce the treatment with a nanotechnology drug delivery system. What if we combined our U.S. military bases with a 10,000 person, Harvard Medical School (M.D., D.O.) team for this?

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.